A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses

OBJECTIVES: Emerging drug resistance to antiviral therapies is an increasing challenge for the treatment of influenza virus infections. One new antiviral compound, BTA938, a dimeric derivative of the viral neuraminidase inhibitor zanamivir, contains a 14-carbon linker bridging two zanamivir moieties...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Tarbet, E. Bart, Hamilton, Stephanie, Vollmer, Almut H., Luttick, Angela, Ng, Wy Ching, Pryor, Melinda, Hurst, Brett L., Crawford, Simon, Smee, Donald F., Tucker, Simon P.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2014
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4100710/
https://ncbi.nlm.nih.gov/pubmed/24777908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dku127
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares